Skip to main content
. 2021 Dec 13;5(23):5420–5428. doi: 10.1182/bloodadvances.2021005507

Figure 2.

Figure 2.

NUDT15 variant frequency in patients with SMNs after ALL treatment. Comparisons of the frequency of NUDT15 variant cases between the SMN cohort and gnomAD database are shown. Six (42.9%) of 14 patients with SMNs after ALL treatment had NUDT15 heterozygous variants, whereas prevalence in the general East Asian population in the gnomAD database was 19.7%. (P = .042). WT, wild type.